{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:04:21Z","timestamp":1790240661248,"version":"4.1.0"},"reference-count":37,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["RC-2025-2796962"],"award-info":[{"award-number":["RC-2025-2796962"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Colorectal cancer (CRC) is one of the most frequently diagnosed malignancies and a leading cause of cancer-related mortality worldwide. Its development and progression are driven by a complex interplay of genetic and epigenetic alterations that contribute to marked biological heterogeneity and variable clinical outcomes. Comprehensive molecular profiling is therefore essential for accurately characterizing CRC and guiding personalized therapeutic strategies. In this context, next-generation sequencing (NGS) has emerged as a powerful tool, enabling high-throughput, simultaneous detection of multiple clinically relevant genomic alterations in a single assay. Methods: We report our experience with a laboratory-designed NGS panel for the routine assessment of advanced-stage CRC. A total of 611 colorectal cancer specimens were analyzed using a laboratory-developed multi-gene NGS panel targeting 229 amplicons across 25 oncogenes and tumor suppressor genes. Results: The panel demonstrated analytical feasibility, with unsuccessful results observed in only 1.3% of the analyzed samples, due to low-quality\/quantity DNA. RAS genes (KRAS and NRAS, altered in 51.2% and 2.7% of cases, respectively), together with BRAF (10.6%), PIK3CA (16.1%), SMAD4 (11.8%), and TP53 (64.3%), represented the most frequently altered molecular markers in the studied cohort. The frequency of major actionable genetic alterations in CRC was comparable between primary (n = 482) and metastatic (n = 121) lesions, suggesting similar mutation frequencies across the groups. Conclusions: This study presents a laboratory-developed multi-gene NGS panel specifically designed for molecular profiling of CRC in routine clinical practice.<\/jats:p>","DOI":"10.3390\/diagnostics16193091","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:06:37Z","timestamp":1790237197000},"page":"3091","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Laboratory-Developed NGS Panel for Characterization of Advanced Colorectal Cancer, Real-World Data from a Tertiary Referral Centre"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3110-3865","authenticated-orcid":false,"given":"Floriana Jessica","family":"Di Paola","sequence":"first","affiliation":[{"name":"Biobank of Research, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-238X","authenticated-orcid":false,"given":"Giulia","family":"Calafato","sequence":"additional","affiliation":[{"name":"Biobank of Research, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-4653","authenticated-orcid":false,"given":"Thais","family":"Maloberti","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Laura","family":"Poppi","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Giulia","family":"Ciccimarra","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1475-4044","authenticated-orcid":false,"given":"Sara","family":"Coluccelli","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Viviana","family":"Sanza","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4334-6170","authenticated-orcid":false,"given":"Elisa","family":"Gruppioni","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9944-2455","authenticated-orcid":false,"given":"Annalisa","family":"Altimari","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3761-5135","authenticated-orcid":false,"given":"Antonio","family":"De Leo","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-8817","authenticated-orcid":false,"given":"Dario","family":"de Biase","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-6682","authenticated-orcid":false,"given":"Giovanni","family":"Tallini","sequence":"additional","affiliation":[{"name":"Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global Burden of Colorectal Cancer: Emerging Trends, Risk Factors and Prevention Strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global Patterns and Trends in Colorectal Cancer Incidence and Mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global Colorectal Cancer Burden in 2020 and Projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive Molecular Characterization of Human Colon and Rectal Cancer","volume":"487","author":"Muzny","year":"2012","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12967-016-1053-z","article-title":"Prognostic Impact of KRAS, NRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Carcinomas: A Population-Based Study","volume":"14","author":"Palomba","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13073-022-01093-z","article-title":"Single-Cell Genomic and Transcriptomic Landscapes of Primary and Metastatic Colorectal Cancer Tumors","volume":"14","author":"Wang","year":"2022","journal-title":"Genome Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kang, D., Li, J., Li, Y., Xu, J., Yang, J., and Zhang, Z. (2025). Prognostic Significance of KRAS, NRAS, BRAF, and PIK3CA Mutations in Stage II\/III Colorectal Cancer: A Retrospective Study and Meta-Analysis. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0320783"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez, M.R., Biedma, B.A., Rodr\u00edguez P\u00e9rez, I., and Romeo, J.A. (2025). Elucidating the Role of KRAS, NRAS, and BRAF Mutations and Microsatellite Instability in Colorectal Cancer via Next-Generation Sequencing. Cancers, 17.","DOI":"10.3390\/cancers17132071"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Cathomas, G. (2014). PIK3CA in Colorectal Cancer. Front. Oncol., 4.","DOI":"10.3389\/fonc.2014.00035"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/jclinpath-2021-207468","article-title":"Multi-Gene Custom Panels for the Characterisation of Metastatic Colorectal Carcinoma in Clinical Practice: Express the Role of PIK3CA Mutations","volume":"75","author":"Malapelle","year":"2022","journal-title":"J. Clin. Pathol."},{"key":"ref_11","first-page":"97","article-title":"Analysis of PIK3CA Mutation Prevalence Variation among Colorectal Cancer Populations: A Comprehensive Review","volume":"53","author":"Vital","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wang, H., Tang, R., Jiang, L., and Jia, Y. (2024). The Role of PIK3CA Gene Mutations in Colorectal Cancer and the Selection of Treatment Strategies. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1494802"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fang, T., Liang, T., Wang, Y., Wu, H., Liu, S., Xie, L., Liang, J., Wang, C., and Tan, Y. (2021). Prognostic Role and Clinicopathological Features of SMAD4 Gene Mutation in Colorectal Cancer: A Systematic Review and Meta-Analysis. BMC Gastroenterol., 21.","DOI":"10.1186\/s12876-021-01864-9"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1038\/s41598-021-87486-3","article-title":"Enhancing the Landscape of Colorectal Cancer Using Targeted Deep Sequencing","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Conroy, J.M., Pabla, S., Glenn, S.T., Seager, R.J., van Roey, E., Gao, S., Burgher, B., Andreas, J., Giamo, V., and Mallon, M. (2021). A Scalable High-Throughput Targeted next-Generation Sequencing Assay for Comprehensive Genomic Profiling of Solid Tumors. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260089"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Isaic, A., Motofelea, N., Hoinoiu, T., Motofelea, A.C., Leancu, I.C., Stan, E., Gheorghe, S.R., Dutu, A.G., and Crintea, A. (2025). Next-Generation Sequencing: A Review of Its Transformative Impact on Cancer Diagnosis, Treatment, and Resistance Management. Diagnostics, 15.","DOI":"10.3390\/diagnostics15192425"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"de Biase, D., Acquaviva, G., Visani, M., Sanza, V., Argento, C.M., De Leo, A., Maloberti, T., Pession, A., and Tallini, G. (2020). Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel. Diagnostics, 10.","DOI":"10.3390\/diagnostics10040250"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Maloberti, T., De Leo, A., Coluccelli, S., Sanza, V., Gruppioni, E., Altimari, A., Comito, F., Melotti, B., Marchese, P.V., and Dika, E. (2024). Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel. Diagnostics, 14.","DOI":"10.3390\/diagnostics14080800"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer","volume":"360","author":"Hitre","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer","volume":"369","author":"Douillard","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer","volume":"381","author":"Kopetz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer","volume":"383","author":"Shiu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(16)00150-9","article-title":"Dual-Targeted Therapy with Trastuzumab and Lapatinib in Treatment-Refractory, KRAS Codon 12\/13 Wild-Type, HER2-Positive Metastatic Colorectal Cancer (HERACLES): A Proof-of-Concept, Multicentre, Open-Label, Phase 2 Trial","volume":"17","author":"Trusolino","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children","volume":"378","author":"Drilon","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.annonc.2024.04.005","article-title":"Recommendations for the Use of Next-Generation Sequencing (NGS) for Patients with Advanced Cancer in 2024: A Report from the ESMO Precision Medicine Working Group","volume":"35","author":"Mosele","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of Metastatic Colorectal Cancer: ASCO Guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic Colorectal Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Afolabi, H.A., Salleh, S.M., Zakaria, Z., Ch\u2019ng, E.S., Mohd Nafi, S.N., Abdul Aziz, A.A.B., Irekeola, A.A., Wada, Y., and Al-Mhanna, S.B. (2022). A GNAS Gene Mutation\u2019s Independent Expression in the Growth of Colorectal Cancer: A Systematic Review and Meta-Analysis. Cancers, 14.","DOI":"10.3390\/cancers14225480"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/ajcp\/aqab023","article-title":"IDH1 and IDH2 Mutations in Colorectal Cancers","volume":"156","author":"Huang","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12032-016-0820-2","article-title":"Targeted Molecular Profiling of Rare Genetic Alterations in Colorectal Cancer Using Next-Generation Sequencing","volume":"33","author":"Jauhri","year":"2016","journal-title":"Med. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S2468-1253(18)30117-1","article-title":"Mutation Burden and Other Molecular Markers of Prognosis in Colorectal Cancer Treated with Curative Intent: Results from the QUASAR 2 Clinical Trial and an Australian Community-Based Series","volume":"3","author":"Domingo","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1200\/JCO.24.00186","article-title":"Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors","volume":"42","author":"Johannet","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_34","first-page":"663","article-title":"MED12 Is Recurrently Mutated in Middle Eastern Colorectal Cancer","volume":"67","author":"Siraj","year":"2018","journal-title":"Gut"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s13059-014-0454-7","article-title":"Comparative Sequencing Analysis Reveals High Genomic Concordance between Matched Primary and Metastatic Colorectal Cancer Lesions","volume":"15","author":"Brannon","year":"2014","journal-title":"Genome Biol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lee, S.E., Park, H.Y., Hwang, D.Y., and Han, H.S. (2021). High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115561"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Malvi, D., Vasuri, F., Maloberti, T., Sanza, V., De Leo, A., Fornelli, A., Masetti, M., Benini, C., Lombardi, R., and Offi, M.F. (2022). Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel. Diagnostics, 12.","DOI":"10.3390\/diagnostics12051058"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/19\/3091\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:24:46Z","timestamp":1790238286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/19\/3091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":37,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["diagnostics16193091"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16193091","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}